Valeo Pharma is committed to provide healthcare professionals and patients with therapeutic solutions.
Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions. Valeo Pharma concentrates on the commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 2, 2022 | Post-IPO Debt | $40M | 1 | Sagard Healthcare Royalty Partners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sagard Healthcare Royalty Partners | Yes | Post-IPO Debt |